Oxalo Therapeutics

$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2025 →

Top agencies

The agencies that pay Oxalo Therapeutics, by dollars committed.

The assistance programs behind Oxalo Therapeutics's money, by dollars committed.

The largest individual awards to Oxalo Therapeutics.

All years — the FY2025 selector does not scope this section

The Treasury accounts Oxalo Therapeutics's awards draw on. Dollars committed on awards that span more than one account are split evenly across them.

All years — the FY2025 selector does not scope this section

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services
075-0884
$2.3M
1 awards
Research and Related Activities, National Science Foundation
049-0100
$1.2M
2 awards

Dollars committed to Oxalo Therapeutics, per fiscal year (FY2018–FY2025).

Committed to this recipient: The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
Lifetime vs. a single year: The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
“Active in FY X”: A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
Names come raw: Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
The colored bars: Every bar on this page splits by how the money moves:
Direct payments

Fiscal year

Federal recipient

$0 committed in FY2025 — no awards to them that year.See all years →Jump to FY2025 →

The agencies that pay Oxalo Therapeutics, by dollars committed.

The assistance programs behind Oxalo Therapeutics's money, by dollars committed.

The largest individual awards to Oxalo Therapeutics.

All years — the FY2025 selector does not scope this section

The Treasury accounts Oxalo Therapeutics's awards draw on. Dollars committed on awards that span more than one account are split evenly across them.

All years — the FY2025 selector does not scope this section

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services
075-0884
$2.3M
1 awards
Research and Related Activities, National Science Foundation
049-0100
$1.2M
2 awards

Dollars committed to Oxalo Therapeutics, per fiscal year (FY2018–FY2025).

Committed to this recipient: The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.
Lifetime vs. a single year: The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.
“Active in FY X”: A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.
Names come raw: Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.
The colored bars: Every bar on this page splits by how the money moves:
Direct payments